Monday, 30 December 2013

Actemra May Have Lipid Benefits (CME/CE)

(MedPage Today) -- Patients with rheumatoid arthritis treated with the interleukin-6 receptor blocker tocilizumab (Actemra) experienced the expected increases in lipids, but also had favorable alterations in certain types of lipid particles, researchers found. via MedPageToday.com - medical news plus CME for physicians Read More Here..

No comments:

Post a Comment